Skip to main content

Cancer Medicine

Cancer Medicine

Edited By:Qingyi Wei, M.D., Ph.D.

Vol 6(12 Issues in 2017 )

Online ISSN: 2045-7634

Impact Factor: 3.362

Digital version available through Wiley Online Library

Select type: Journal


Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of cutting-edge research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

Cancer Biology
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery

Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations

Cancer Prevention
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach

Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.

We aim to be a truly global forum for high-quality cancer research, and we think that the best research should be published and made widely accessible as quickly as possible. Cancer Medicine publishes papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley-Blackwell. List available here.

Cancer Medicine is a Wiley Open Access journal, one of a new series of peer reviewed titles publishing quality research with speed and efficiency. For further information visit the Wiley Open Access website.

Open Access and Copyright
All articles published by Cancer Medicine are fully open access: immediately freely available to read, download and share. All Cancer Medicine articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Copyright on any research article in a journal published by Cancer Medicine is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Further information about open access license and copyright can be found here.

Peer review policy
Cancer Medicine maintains the highest standards of peer review while increasing the efficiency of the process. All research articles published in the journal will undergo full peer review, and we pursue editorial approaches that may help us avoid bias. We will do our utmost to judge research objectively on its own merits and to avoid favoring research, for example, from particular institutions, countries, or regions. Key characteristics of the journal’s review process are:
• All research articles submitted directly to the Journal are initially evaluated by the Editor-in-Chief; articles found appropriate for the Journal will be reviewed by at least two suitably qualified experts.
• All manuscripts submitted directly to Cancer Medicine will be subject to double-blind peer review.
• Most submissions transferred to Cance